Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,026 | 37,950 | 60,162 | 0 | N/A |
| Marketable Securities | 12,015 | 11,326 | N/A | 0 | N/A |
| Receivables | 215 | 440 | 392 | 0 | N/A |
| TOTAL | $84,942 | $49,869 | $60,703 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,476 | 1,879 | 2,602 | 0 | N/A |
| Other Non-Current Assets | 0 | 2,739 | 0 | 0 | 0 |
| TOTAL | $2,476 | $4,618 | $2,602 | $N/A | $N/A |
| Total Assets | $87,418 | $54,487 | $63,305 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,664 | 2,283 | 2,181 | 0 | 0 |
| TOTAL | $14,286 | $18,203 | $19,196 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 1,665 | 0 | N/A |
| Deferred Revenues | 11,622 | 15,920 | 17,015 | N/A | N/A |
| TOTAL | $353 | $12,168 | $31,486 | $N/A | $N/A |
| Total Liabilities | $14,639 | $30,371 | $50,682 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,222 | N/A | N/A | N/A | N/A |
| Common Shares | 147,157 | 6,147 | 6,008 | 0 | N/A |
| Retained earnings | -103,734 | -116,752 | -128,784 | 0 | N/A |
| Other shareholders' equity | -990 | 104,999 | 106,235 | 0 | 0 |
| TOTAL | $72,779 | $24,116 | $12,623 | $0 | $N/A |
| Total Liabilities And Equity | $87,418 | $54,487 | $63,305 | $0 | $0 |